Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
They're often sold as research chemicals "not for human consumption," despite widespread human use
Use High-Quality, Medical-Grade Peptides Purity, sterilization, and potency matter
These vitamin injections rarely cause any side effects
DISSECTION P2381 - ESOC25-1554 OPTIMIZING PATIENT SELECTION FOR FIRST-LINE RITUXIMAB THERAPY IN PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM Jaroslava Paulasova Schwabova 1 , Katerina Benesova 1 , Tereza Ruzickova 1 , Silvia Kmetonyova 1 , Martin Elisak 1 , Ivana Sarbochova 1 , Hana Magerova 1 , Anna Olserova 1 , Jansky Petr 1 , Ales Tomek 1 1 1Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic Background and Aims: Primary angiitis of the central nervous system (PACNS) is a rare yet serious condition, often challenging to diagnose and treat
US$ 28.02
US$ 26.23
US$ 25.69
US$ 21.75
US$ 28.31